These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8463997)

  • 1. Characterization of [3H]SK&F 108566 as a radioligand for angiotensin type-1 receptor.
    Aiyar N; Griffin E; Shu A; Heys R; Bergsma DJ; Weinstock J; Edwards R
    J Recept Res; 1993; 13(5):849-61. PubMed ID: 8463997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of bovine ovary angiotensin II receptors using subtype-selective antagonists.
    Aiyar N; Griffin E; Edwards R; Weinstock J; Samanen J; Nambi P
    Pharmacology; 1993; 46(1):1-8. PubMed ID: 8434027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of valsartan to mammalian angiotensin AT1 receptors.
    de Gasparo M; Whitebread S
    Regul Pept; 1995 Nov; 59(3):303-11. PubMed ID: 8577935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for AT2 receptors.
    Chang RS; Lotti VJ; Chen TB; O'Malley SS; Bendesky RJ; Kling PJ; Kivlighn SD; Siegl PK; Ondeyka D; Greenlee WJ
    Eur J Pharmacol; 1995 Dec; 294(2-3):429-37. PubMed ID: 8750703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle.
    Sung CP; Arleth AJ; Storer BL; Ohlstein EH
    J Pharmacol Exp Ther; 1994 Oct; 271(1):429-37. PubMed ID: 7965744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the binding of [3H]L-158,809: a new potent and selective nonpeptide angiotensin II receptor (AT1) antagonist radioligand.
    Chen TB; Lotti VJ; Chang RS
    Mol Pharmacol; 1992 Dec; 42(6):1077-82. PubMed ID: 1480133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of renal angiotensin II receptors using subtype selective antagonists.
    Edwards RM; Stack EJ; Weidley EF; Aiyar N; Keenan RM; Hill DT; Weinstock J
    J Pharmacol Exp Ther; 1992 Mar; 260(3):933-8. PubMed ID: 1545405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells.
    Gopalakrishnan V; Xu YJ; Sulakhe PV; Triggle CR; McNeill JR
    Am J Physiol; 1991 Dec; 261(6 Pt 2):H1927-36. PubMed ID: 1836312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells.
    Briand V; Riva L; Galzin AM
    Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of tissue freezing on the binding of 125I-sarcosine1, isoleucine8 angiotensin II to angiotensin II receptor subtypes in the rat.
    Lu XY; Zhang W; Grove KL; Speth RC
    J Pharmacol Toxicol Methods; 1995 Apr; 33(2):83-90. PubMed ID: 7766920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
    Edwards RM; Aiyar N; Ohlstein EH; Weidley EF; Griffin E; Ezekiel M; Keenan RM; Ruffolo RR; Weinstock J
    J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.
    Inada Y; Nakane T; Chiba S
    Fundam Clin Pharmacol; 2002 Aug; 16(4):317-23. PubMed ID: 12570021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
    Stassen FL; Heckman G; Schmidt D; Nambi P; Aiyar N; Landvatter S; Crooke ST
    Mol Pharmacol; 1987 Mar; 31(3):267-72. PubMed ID: 2951585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the binding of [125I]L-735,286: a new nonpeptide angiotensin II AT1 receptor radioligand.
    Chen TB; Brenner NJ; Gibson RE; Burns HD; Chang RS
    Life Sci; 1995; 56(8):629-35. PubMed ID: 7869841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of tissue- and subtype-specific modulation of angiotensin II receptors using antibodies against AT1 and AT2 receptors.
    Rakugi H; Okamura A; Kamide K; Ohishi M; Sasamura H; Morishita R; Higaki J; Ogihara T
    Hypertens Res; 1997 Mar; 20(1):51-5. PubMed ID: 9101313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the AT1 subtype of the angiotensin II receptor in the rat submandibular gland.
    Matsubara S; Saito K; Kizawa Y; Sano M; Osawa M; Iwamoto K; Murakami H
    Biol Pharm Bull; 2000 Oct; 23(10):1185-8. PubMed ID: 11041248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II and non-angiotensin II displaceable binding sites for [3H]losartan in the rat liver.
    Grove KL; Speth RC
    Biochem Pharmacol; 1993 Nov; 46(9):1653-60. PubMed ID: 8240422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.
    Chiu AT; McCall DE; Aldrich PE; Timmermans PB
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1195-202. PubMed ID: 2244903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.